Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to $35.6 million.

  • Vanda Pharmaceuticals' Change in Acquisitions & Divestments fell 6292.9% to $35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $257.8 million, marking a year-over-year decrease of 2984.95%. This contributed to the annual value of $352.1 million for FY2024, which is 4147.89% down from last year.
  • Per Vanda Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $35.6 million for Q3 2025, which was down 6292.9% from $38.0 million recorded in Q2 2025.
  • Vanda Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $350.4 million during Q1 2023, with a 5-year trough of $35.6 million in Q3 2025.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $87.7 million (2025), whereas its average is $97.8 million.
  • Per our database at Business Quant, Vanda Pharmaceuticals' Change in Acquisitions & Divestments skyrocketed by 28899.81% in 2023 and then tumbled by 8273.35% in 2024.
  • Over the past 5 years, Vanda Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $79.4 million in 2021, then rose by 0.74% to $80.0 million in 2022, then skyrocketed by 40.14% to $112.1 million in 2023, then fell by 13.83% to $96.6 million in 2024, then tumbled by 63.18% to $35.6 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $35.6 million for Q3 2025, versus $38.0 million for Q2 2025 and $87.7 million for Q1 2025.